Funding for this research was provided by:
National Institutes of Health (K01TW009488, R21CA180815, U54CA190152)
Medical Education Partnership Initiative (U2GPS001965)
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (P30CA016086)
Received: 23 May 2018
Accepted: 22 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: All patients provided written informed consent for participation in the Kamuzu Central Hospital Lymphoma Study, which was approved by the Malawi National Health Sciences Research Committee (1107) and University of North Carolina Biomedical Institutional Review Board (12–2255).
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.